Doxorubicin was demonstrated to be effective in induction of apoptosis in prostate cancer, by activating p53-mediated pathway to exert their anti-cancer effects by causing DNA damage and initiating cell cycle arrest in cancer cells (Yang et al., 2016). This evidence concerns the gene TP53 and prostate carcinoma.